Since the correlation between T-tau level in CSF and NPI score did not reach a significant level, we will in the future measure the volume of specific brain regions relevant to NPSs by magnetic resonance imaging in addition to enhancing CSF samples from patients with PD, which may further validate the conclusion from this study. The gene discussed is MAPT; the disease is Parkinson disease.